An investor in NASDAQ:MCRB shares filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged Securities Laws violations by Seres Therapeutics Inc. Investors who purchased shares of Seres Therapeutics Inc (NASDAQ:MCRB) have certain options and for certain investors are short and strict deadlines running. Deadline: November 29, 2016. NASDAQ:MCRB investors […]
Investor News: Lawsuit against Juno Therapeutics Inc (NASDAQ:JUNO) alleges Misleading Statements
An investor in NASDAQ:JUNO shares filed a lawsuit in the over alleged violations of Federal Securities Laws by Juno Therapeutics Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO) have certain options and for certain investors are short and strict deadlines running. Deadline: September 12, […]
Investor News: Lawsuit filed against certain directors of Sorrento Therapeutics Inc (NASDAQ:SRNE)
An investor in NASDAQ:SRNE shares filed a lawsuit against certain directors of Sorrento Therapeutics Inc over alleged breaches of fiduciary duties. Investors who purchased shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) and currently hold any of those NASDAQ:SRNE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. […]
Investor News: Investigation of Esperion Therapeutics Inc (NASDAQ:ESPR) over potential Misconduct
An investigation for investors in NASDAQ:ESPR shares concerning potential breaches of fiduciary duties by certain directors of Esperion Therapeutics Inc was announced. Investors who are current long term investors in Esperion Therapeutics Inc (NASDAQ:ESPR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation by […]
Investor News: Investigation of Osiris Therapeutics, Inc. (NASDAQ:OSIR) over possible Wrongdoing
An investigation for investors in NASDAQ:OSIR shares was announced over potential breaches of fiduciary duties by certain directors at Columbia MD based Osiris Therapeutics. Investors who purchased shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) and currently hold any of those NASDAQ:OSIR shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) […]
Investor News: Investigation of certain Directors of Insys Therapeutics Inc (NASDAQ:INSY)
An investigation for investors in NASDAQ:INSY shares concerning potential breaches of fiduciary duties by certain directors of Insys Therapeutics Inc was announced. Shares of Insys Therapeutics Inc (NASDAQ:INSY) declined from $44.74 per share in August 2-015 to as low as $12.21 per share on May 12, 2016. Investors who are current long term investors in […]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 38
- Next Page »